Transcription factors as targets for cancer therapy (original) (raw)

• Varmus, H. E. Oncogenes and transcriptional control. Science 238, 1337–1339 (1987).
  Article CAS PubMed Google Scholar
• Blume-Jensen, P. & Hunter, T. Oncogenic kinase signalling. Nature 411, 355–365 (2001).
  Article CAS PubMed Google Scholar
• Vogt, P. K. Jun, the oncoprotein. Oncogene 20, 2365–2377 (2001).The discoverer of JUN presents an excellent summary of the first nuclear oncogene.
  Article CAS PubMed Google Scholar
• Futreal, P. A. et al. Cancer and genomics. Nature 409, 850–852 (2001).
  Article CAS PubMed Google Scholar
• Green, D. R. & Evan, G. I. A matter of life and death. Cancer Cell 1, 19–30 (2002).Authoritative account of the importance of apoptosis in cancer.
  Article CAS PubMed Google Scholar
• Gibbs, J. B. Mechanism-based target identification and drug discovery in cancer. Science 287, 1969–1973 (2000).
  Article CAS PubMed Google Scholar
• Biederer, C., Ries, S., Bandts, C. H. & McCormick, F. Replication-selective viruses for cancer therapy. J. Mol. Med. 80, 163–175 (2002).
  Article CAS PubMed Google Scholar
• McCormick, F. Cancer gene therapy: fringe or cutting edge? Nature Rev. Cancer 1, 130–141 (2001).
  Article CAS Google Scholar
• Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 100, 57–70 (2000).Widely quoted summary of the requirements to make a human cancer cell.
  Article CAS PubMed Google Scholar
• Bachur, N. R. in Encyclopedia of Cancer 2nd edn Vol. 1 (ed. Bertino, J. R.) 57–61 (Academic Press, 2002).
  Book Google Scholar
• Tilley, W. D., Clarke, C. L., Birrell, S. N. & Bruchovsky, N. Hormones and cancer: new insights, new challenges. Trends Endocrinol. Metab. 12, 186–188 (2001).
  Article CAS PubMed Google Scholar
• Barnes, P. J. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin. Sci. 94, 557–572 (1998).
  Article CAS Google Scholar
• Brivanlou, A. H. & Darnell, J. E. Jr., Signal transduction and the control of gene expression. Science 295, 813–818 (2002).
  Article CAS PubMed Google Scholar
• Vogt, P. K., Bos, T. J. & Doolittle, R. F. Homology between the DNA-binding domain of the GCN4 regulatory protein of yeast and the carboxyl-terminal region of a protein coded for by the oncogene jun. Proc. Natl Acad. Sci. USA 84, 3316–3319 (1987).
  Article CAS PubMed PubMed Central Google Scholar
• Derijard, B. et al. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76, 1025–1037 (1994).
  Article CAS PubMed Google Scholar
• Denhardt, D. T. Oncogene-initiated aberrant signaling engenders the metastatic phenotype: synergistic transcription factor interactions are targets for cancer therapy. Crit. Rev. Oncog. 7, 261–291 (1996).
  Article CAS PubMed Google Scholar
• Stark, G. R., Kerrr, I. M., Williams, B. R., Silverman, R. H. & Schreiber, R. D. How cells respond to interferons. Annu. Rev. Biochem. 67, 227–264 (1998).
  Article CAS PubMed Google Scholar
• Levy, D. & Darnell, J. E. Jr., STATs: transcriptional control and biologic impact. Nature Rev. Mol. Cell Biol. 3, 651–662 (2002).Most up-to-date review of the STAT protein family, which is important in cancer.
  Article CAS Google Scholar
• Darnell, J. E. Jr., STATs and gene regulation. Science 277, 1630–1635 (1997).
  Article CAS PubMed Google Scholar
• Groner, B. et al. Regulation of the trans-activation potential of STAT5 through its DNA-binding activity and interactions with heterologous transcription factors. Growth Horm. IGF Res. 10 (Suppl. B), S15–S20 (2000).
  Article PubMed Google Scholar
• Aittomaki, S. et al. Cooperation among Stat1, glucocorticoid receptor, and PU.1 in transcriptional activation of the high-affinity Fc gamma receptor I in monocytes. J. Immunol. 164, 5689–5697 (2000).
  Article CAS PubMed Google Scholar
• Look, D. C., Pelletier, M. R., Tidwell, R. M., Roswit, W. T. & Holtzman, M. J. Stat1 depends on transcriptional synergy with Sp1. J. Biol. Chem. 270, 30264–30267 (1995).
  Article CAS PubMed Google Scholar
• Zhang, X., Wrzeszczynaska, M. H., Horvath, C. M. & Darnell, J. E. Jr., Interacting regions in Stat3 and c-Jun that participate in cooperative transcriptional activation. Mol. Cell. Biol. 19, 7138–7146 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Starr, R. & Hilton, D. J. Negative regulation of the JAK/STAT pathway. Bioessays 21, 47–52 (1999).Authoritative summary of how cells switch off this important signalling pathway.
  Article CAS PubMed Google Scholar
• Aoki, N. & Matsuda, T. A nuclear protein tyrosine phosphatase TC-PTP is a potential negative regulator of the PRL-mediated signaling pathway: dephosphorylation and deactivation of signal transducer and activator of transcription 5a and 5b by TC-PTP in nucleus. Mol. Endocrinol. 16, 58–69 (2002).
  Article CAS PubMed Google Scholar
• Shuai, K. Modulation of STAT signaling by STAT-interacting proteins. Oncogene 19, 2638–2644 (2000).
  Article CAS PubMed Google Scholar
• Yu, C. L. et al. Enhanced DNA-binding of a Stat3-related protein in cells transformed by the Src oncoprotein. Science 269, 81–83 (1995).
  Article CAS PubMed Google Scholar
• Bowman, T., Garcia, R., Turkson, J. & Jove, R. STATs in oncogenesis. Oncogene 19, 2474–2488 (2000).
  Article CAS PubMed Google Scholar
• Bromberg, J. F. et al. Stat3 as an oncogene. Cell 98, 295–303 (1999).
  Article CAS PubMed Google Scholar
• Takeda, K. et al. Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell- specific Stat3-deficient mice. J. Immunol. 161, 4652–4660 (1998).
  CAS PubMed Google Scholar
• Takeda, K. et al. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 10, 39–49 (1999).
  Article CAS PubMed Google Scholar
• Shen, Y., Devgan, G., Darnell, J. E. Jr, & Bromberg, J. F. Constitutively activated Stat3 protects fibroblasts from serum withdrawal and UV-induced apoptosis and antagonizes the proapoptotic effects of activated Stat1. Proc. Natl Acad. Sci. USA 98, 1543–1548 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Lacaronique, V. et al. A TEL–JAK2 fusion protein with constitutive kinase activity in human leukemia. Science 278, 1309–1312 (1997).
  Article Google Scholar
• Lacronique, V. et al. Transforming properties of chimeric TEL–JAK proteins in Ba/F3 cells. Blood 95, 2076–2083 (200).
• Song, J. I. & Grandis, J. R. STAT signaling in head and neck cancer. Oncogene 19, 2489–2495 (2000).Importance of persistently active STAT3 in human cancer.
  Article CAS PubMed Google Scholar
• Catlett-Falcone, R. et al. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 10, 105–115 (1999).
  Article CAS PubMed Google Scholar
• Yoshikawa, H. et al. SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nature Genet. 28, 29–35 (2001).
  CAS PubMed Google Scholar
• Zhang, Q. et al. Multilevel dysregulation of STAT3 activation in anaplastic lymphoma kinase-positive T/null-cell lymphoma. J. Immun. 168, 466–474 (2002).References 36–38 provide evidence of the importance of STAT3 in clinical cancer.
  Article CAS PubMed Google Scholar
• Perkins, N. D. The Rel/NF-κB family: friend and foe. Trends Biochem. Sci. 25, 434–440 (2000).
  Article CAS PubMed Google Scholar
• Israel, A. IκB kinase all zipped up. Nature 388, 519–521 (1997).
  CAS PubMed Google Scholar
• Sen, R. & Baltimore, D. Inducibility of kappa immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism. Cell 47, 921–928 (1986).
  Article CAS PubMed Google Scholar
• Tam, W. F., Wang, W. & Sen, R. Cell-specific association and shuttling of IκBα provides a mechanism for nuclear NF-κB in B lymphocytes. Mol. Cell. Biol. 21, 4837–4846 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Song, H. Y., Rothe, M. & Goeddel, D. V. The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-κB activation. Proc. Natl Acad. Sci. USA 93, 6721–6725 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Thanos, D. & Maniatis, T. Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome. Cell 83, 1091–1101 (1995).Early description of the protein complex that functions as the enhanceosome.
  Article CAS PubMed Google Scholar
• Rayet, B. & Gelinas, C. Aberrant REL/NF-κB genes and activity in human cancer. Oncogene 18, 6938–6947 (1999).
  Article CAS PubMed Google Scholar
• Ni, H. et al. Analysis of expression of nuclear factor B (NF-κB) in multiple myeloma: downregulation of NF-κB induces apoptosis. Br. J. Haematol. 115, 279–286 (2001).
  Article CAS PubMed Google Scholar
• Izban, K. F. et al. Characterization of NF-κB expression in Hodgkin's disease: inhibition of constitutively expressed NF-κB results in spontaneous caspase-independent apoptosis in Hodgkin and Reed–Sternberg cells. Mod. Pathol. 14, 297–310 (2001).
  Article CAS PubMed Google Scholar
• Kim, D. W. et al. Activation of NF-κB/REL occurs early during neoplastic transformation of mammary cells. Carcinogenesis 21, 871–879 (2000).
  Article PubMed Google Scholar
• Tai, D. I. et al. Constitutive activation of nuclear factor kappaB in hepatocellular carcinoma. Cancer 89, 2274–2281 (2000).
  Article CAS PubMed Google Scholar
• Taipale, J. & Beachy, P. A. The Hedgehog and Wnt signalling pathways in cancer. Nature 411, 349–354 (2001).Excellent review of two signalling pathways and how they might connect to human cancer.
  Article CAS PubMed Google Scholar
• Barish, G. D. & Williams, B. O. in Signaling Networks and Cell Cycle Control (ed. Gutkind, J. S) 53–82 (2000).
  Book Google Scholar
• Kolligs, F. T. et al. Gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin. Genes Dev. 14, 1319–1331 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Wong, C. M., Fan, S. T. & Ng, I. O. L. Beta-catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance. Cancer 92, 136–145 (2001).
  Article CAS PubMed Google Scholar
• van de Wetering, M. et al. Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF. Cell 88, 789–799 (1997).
  Article CAS PubMed Google Scholar
• Kramps, T. et al. Wnt/wingless signaling requires BCL9/legless-mediated recruitment of pygopus to the nuclear beta-catenin-TCF complex. Cell 109, 47–60 (2002).
  Article CAS PubMed Google Scholar
• Parker, D. S., Jemison, J. & Cadigan, K. M. Nucleotide Pygopus, a nuclear PHD-finger protein required for Wingless signaling in Drosophila. Development 129, 2565–2576 (2002).
  Article CAS PubMed Google Scholar
• Thompson, B., Townsley, F., Rosin-Arbesfeld, R., Musisi, H. & Bienz, M. A new nuclear component of the Wnt signalling pathway. Nature Cell Biol. 4, 367–373 (2002).
  Article CAS PubMed Google Scholar
• Barker, N. & Clevers, H. Catenins, Wnt signaling and cancer. Bioessays 22, 961–965 (2000).
  Article CAS PubMed Google Scholar
• Hovanes, K. et al. Beta-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer. Nature Genet. 28, 53–57 (2001).
  CAS PubMed Google Scholar
• Artavanis-Tsakonas, S., Rand, M. D. & Lake, R. J. Notch signaling: cell fate control and signal integration in development. Science 284, 770–776 (1999).
  Article CAS PubMed Google Scholar
• Weinmaster, G. Notch signal transduction: a real Rip and more. Curr. Opin. Genet. Dev. 10, (2000).Authoritative summary of Notch signalling.
• Davis, R. L. & Turner, D. L. Vertebrate Hairy and Enhancer of split related proteins: transcriptional repressors regulating cellular differentiation and embryonic patterning. Oncogene 20, 8342–9357 (2001).
  Article CAS PubMed Google Scholar
• Jarriault, S. et al. Signalling downstream of activated mammalian Notch. Nature 377, 355–358 (1995).
  Article CAS PubMed Google Scholar
• Oswald, F. et al. p300 acts as a transcriptional coactivator for mammalian Notch-1. Mol. Cell. Biol. 21, 7761–7774 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Ellisen, L. W. et al. TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell 66, 649–661 (1991).Connects the Notch pathway to human cancer.
  Article CAS PubMed Google Scholar
• Callahan, D. & Callahan, R. The mouse mammary tumor associated gene INT3 is a unique member of the NOTCH gene family (NOTCH4). Oncogene 14, 1883–1890 (1997).
  Article PubMed CAS Google Scholar
• Capobianco, A. J., Zagouras, P., Blaumueller, C. M., Artavanis-Tsakonas, S. & Bishop, J. M. Neoplastic transformation by truncated alleles of human NOTCH1/TAN1 and NOTCH2. Mol. Cell. Biol. 17, 6265–6273 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Jang, M. S., Zlobin, A., Kast, W. M. & Miele, L. Notch signaling as a target in multimodality cancer therapy. Curr. Opin. Mol. Ther. 2, 55–65 (2000).
  CAS PubMed Google Scholar
• Fitzgerald, K., Harrington, A. & Leder, P. Ras pathway signals are required for notch-mediated oncogenesis. Oncogene 19, 4191–4198 (2000).
  Article CAS PubMed Google Scholar
• Ingham, P. W. Transducing Hedgehog: the story so far. EMBO J. 17, 3505–3511 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Kalderon, D. Transducing the Hedgehog signal. Cell 103, 371–374 (2000).
  Article CAS PubMed Google Scholar
• Price, M. A. & Kalderon, D. Proteolysis of the Hedgehog signaling effector cubitus interruptus requires phosphorylation by glycogen synthase kinase 3 and casein kinase 1. Cell 108, 823–835 (2002).
  Article CAS PubMed Google Scholar
• Ruiz i Altaba, A. Gli proteins and Hedgehog in signalling. Trends Genet. 15, 418–425 (1999).Connects human cancer with the Hedgehog pathway.
  Article CAS PubMed Google Scholar
• Cheng, S. Y. & Bishop, J. M. Suppressor of Fused represses Gli-mediated transcription by recruiting the SAP18–mSin3 corepressor complex. Proc. Natl Acad. Sci. USA 99, 5442–5447 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Wang, B., Fallon, J. F. & Beachy, P. A. Hedgehog-regulated processing of Gli3 produces an anterior/posterior repressor gradient in the developing vertebrate limb. Cell 100, 423–434 (2000).
  Article CAS PubMed Google Scholar
• Riefenberger, J. et al. Missense mutations in SMO in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res. 58, 1798–1803 (1998).
  Google Scholar
• Goodrich, L. V., Milenkovic, L., Higgins, K. M. & Scott, M. P. Altered neural cell fates and medulloblastoma in mouse patched mutants. Science 277, 1109–1113 (1997).
  Article CAS PubMed Google Scholar
• Hahn, H. et al. Rhabdomyosarcomas and radiation hypersensitivity in a mouse model of Gorlin syndrome. Nature Med. 4, 619–622 (1998).
  Article CAS PubMed Google Scholar
• van Dam, H. & Castelazzi, M. Distinct roles of Jun: Fos and Jun: ATF dimers in oncogenesis. Oncogene 20, 2453–2464 (2001).
  Article CAS PubMed Google Scholar
• Hartl, M. & Vogt, P. K. A rearranged junD transforms chicken embryo fibroblasts. Cell Growth Differ. 3, 909–918 (1992).
  CAS PubMed Google Scholar
• Vandel, L. et al. Stepwise transformation of rat embryo fibroblasts: c-Jun, JunB, or JunD can cooperate with Ras for focus formation, but a c-Jun-containing heterodimer is required for immortalization. Mol. Cell. Biol. 16, 1881–1888 (1996).Emphasizes the importance of multiple events in tumorigenesis.
  Article CAS PubMed PubMed Central Google Scholar
• Gille, H., Strahl, T. & Shaw, P. E. Activation of ternary complex factor Elk-1 by stress-activated protein kinases. Curr. Biol. 5, 1191–1200 (1995).
  Article CAS PubMed Google Scholar
• Davidson, B. et al. Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma. Clin. Cancer Res. 7, 551–557 (2001).
  CAS PubMed Google Scholar
• Shaywitz, A. J. & Greenberg, M. E. CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu. Rev. Biochem. 68, 821–861 (1999).Excellent summary of CREB — one of the most well-studied transcription factors.
  Article CAS PubMed Google Scholar
• Fambrough, D., McClure, K., Kazlauskas, A. & Lander, E. S. Diverse signaling pathways activated by growth factor receptors induce broadly overlapping, rather than independent, sets of genes. Cell 97, 727–741 (1999).
  Article CAS PubMed Google Scholar
• Gilliland, D. G. The diverse role of the ETS family of transcription factors in cancer. Clin. Cancer Res. 7, 451–453 (2001).
  CAS PubMed Google Scholar
• Nesbit, C. E., Tersak, J. M. & Prochownik, E. V. MYC oncogenes and human neoplastic disease. Oncogene 18, 3004–3016 (1999).
  Article CAS PubMed Google Scholar
• Grandori, C., Cowley, S. M., James, L. P. & Eisenman, R. N. The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu. Rev. Cell Dev. Biol. 16, 653–699 (2000).Discoverer of MYC transcriptional activity provides up-to-date summary.
  Article CAS PubMed Google Scholar
• Eisenman, R. N. Deconstructing Myc. Genes Dev. 15, 2023–2030 (2001).
  Article CAS PubMed Google Scholar
• Wu, L. et al. The E2F1-3transcription factors are essential for cellular proliferation. Nature 414, 457–462 (2001).
  Article CAS PubMed Google Scholar
• Eymin, B., Gazzeri, S., Brambilla, C. & Brambilla, E. Distinct pattern of E2F1 expression in human lung tumours: E2F1 is upregulated in small-cell-lung carcinoma. Oncogene 20, 1678–1687 (2001).
  Article CAS PubMed Google Scholar
• Chen, X. et al. Gene expression patterns in human liver cancers. Mol. Biol. Cell. 13, 1929–1939 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Perou, C. M. et al. Molecular portraits of human breast tumours. Nature 406, 747–752 (2000).Among one of the first comprehensive gene-array reports: strengths and weaknesses discussed.
  Article CAS PubMed Google Scholar
• Rosenwald, A. et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N. Engl. J. Med. 346, 1937–1947 (2002).
  Article PubMed Google Scholar
• Davis, R. E. & Staudt, L. M. Molecular diagnosis of lymphoid malignancies by gene expression profiling. Curr. Opin. Hematol. 9, 333–338 (2002).
  Article PubMed Google Scholar
• Abbott, A. News Feature: On the offensive. Nature 416, 470–474 (2002).Summary of where cancer pharmacology stands now.
  Article CAS PubMed Google Scholar
• Malik, H. S., Eickbush, T. H. & Goldfarb, D. S. Evolutionary specialization of the nuclear targeting apparatus. Proc. Natl Acad. Sci. USA 94, 13738–13742 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Malik, S. & Roeder, R. G. Transcriptional regulation through mediator-like coactivators in yeast and metazoan cells. Trends Biochem. Sci. 25, 277–283 (2000).
  Article CAS PubMed Google Scholar
• Park, H. S., Lin, Q. & Hamilton, A. D. Supramolecular chemistry and self-assembly special feature: modulation of protein–protein interactions by synthetic receptors. Design of molecules that disrupt serine protease-proteinaceous inhibitor interaction. Proc. Natl Acad. Sci. USA 99, 5105–5109 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Ohkanda, J., Knowles, D. B., Blaskovich, M. A., Sebti, S. M. & Hamilton, A. D. Inhibitors of protein farnesyltransferase as novel anticancer agents. Curr. Top. Med. Chem. 2, 303–323 (2002).
  Article CAS PubMed Google Scholar
• Peczuh, M. W. & Hamilton, A. D. Peptide and protein recognition by designed molecules. Chem. Rev. 100, 2479–2494 (2000).
  Article CAS PubMed Google Scholar
• Cochran, A. G. Antagonists of protein–protein interactions. Chem. Biol. 7, R85–R94 (2000).
  Article CAS PubMed Google Scholar
• Eckert, D. M., Malashkevich, V. N., Hong, L. H., Carr, P. A. & Kim, P. S. Inhibiting HIV-1 entry: discovery of D-peptide inhibitors that target the gp41 coiled-coil pocket. Cell 99, 103–115 (1999).
  Article CAS PubMed Google Scholar
• Berg, T. et al. Small-molecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblasts. Proc. Natl Acad. Sci. USA 99, 3830–3835 (2002).First description of a small molecule that inhibits transcription-factor dimerization.
  Article CAS PubMed PubMed Central Google Scholar
• McBride, K. M., Banninger, G., McDonald, C. & Reich, N. C. Regulated nuclear import of the STAT1 transcription factor by direct binding of importin-α. EMBO J. 21, 1754–1763 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Haspel, R. L. & Darnell, J. E. Jr. A nuclear protein tyrosine phosphatase is required for the inactivation of Stat1. Proc. Natl Acad. Sci. USA 96, 10188–10193 (1999).
  Article CAS PubMed PubMed Central Google Scholar